Hormetics — Hormones, Metabolism, Genetics Take the Assessment
    Estrogen type icon

    The High Estrogen Type

    When the issue is not how much, but how the body clears it

    In women: weight that settles in the hips and thighs no matter what changes. Heavy cycles. Bloating that worsens before periods. Mood shifts that follow a predictable rhythm. In men: stubborn weight at the chest and waist, lower drive, a sense that the masculine balance has shifted. There is a hormonal explanation that connects all of these.

    The Pattern That Has a Name

    The High Estrogen Type is the fourth of the five hormonal patterns in the Hormetics framework, co-developed by health researcher Elwin Robinson and Dr. Miriam Mikicki MD, an IFM-certified functional medicine physician.

    In women, common features of this pattern include:

    • Weight that accumulates in the hips, thighs, and buttocks (a pear-shaped pattern), regardless of overall body size
    • Heavy or painful menstrual cycles
    • Premenstrual fluid retention and bloating
    • Breast tenderness that worsens cyclically
    • Mood shifts in the second half of the menstrual cycle
    • Difficulty losing lower body weight even with consistent effort
    • Cellulite that does not respond to changes in diet or exercise
    • Worsening of symptoms during perimenopause

    In men, the pattern presents differently:

    • Weight accumulating around the chest and lower abdomen
    • Tissue changes in the chest area
    • Reduced energy, drive, and motivation
    • Emotional reactivity that feels out of character
    • Difficulty building or maintaining muscle mass

    What links these very different presentations is not necessarily a high estrogen exposure, but a relative excess of estrogen activity, often combined with impaired clearance, compared to the other hormones the body uses to balance it ¹.

    What Estrogen Actually Does

    Estrogen pathways infographic showing production, balance, and clearance

    Estrogen is not a single hormone but a family of three: estradiol (E2, the most potent), estrone (E1), and estriol (E3) ². These are produced primarily by the ovaries in women and in smaller amounts by the testes and adrenal glands in men. Notably, fat tissue (adipose tissue) also produces estrogen in both sexes through the action of an enzyme called aromatase ³.

    Estrogens regulate dozens of physiological processes: reproductive function, bone density, cardiovascular health, cognitive function, skin and tissue integrity, mood, fat distribution, and more . The hormones themselves are essential.

    The body uses several mechanisms to keep estrogen activity in balance. One is direct opposition: progesterone, the other major female hormone, balances many of estrogen's effects on tissue growth and fluid retention . Another is clearance: the liver and gut work together to deactivate estrogen and remove it from the body so that levels stay within a healthy range .

    When either of those mechanisms falters, the body drifts toward what is called estrogen dominance, even if absolute estrogen levels are not particularly high.

    When Clearance Breaks Down

    Most discussion of estrogen dominance focuses on production. The more common driver, in clinical observation, is impaired clearance.

    The liver processes estrogen in two main phases :

    Phase 1. A family of enzymes (the cytochrome P450 system, including CYP1A1, CYP1B1, and CYP3A4) converts estrogen into intermediate metabolites. Some of these metabolites (particularly the 2-hydroxyestrone pathway) are relatively benign. Others (the 4-hydroxyestrone pathway) are more reactive and require careful processing .

    Phase 2. The intermediates from Phase 1 are conjugated (attached to other molecules) so they can be excreted. The two main pathways are methylation (requiring methyl donors and B vitamins) and glucuronidation (requiring intact liver function and balanced gut bacteria) .

    If Phase 2 is bottlenecked (insufficient methylation cofactors, impaired glucuronidation, gut dysbiosis), the intermediate metabolites can recirculate, accumulate, and cause downstream effects ¹⁰.

    The gut adds another layer. After estrogen is conjugated in the liver and excreted into the bile, it travels into the intestines for elimination. Certain gut bacteria produce an enzyme called beta-glucuronidase, which can deconjugate the estrogen and allow it to be reabsorbed back into circulation. The collection of estrogen-modulating gut bacteria is called the estrobolome ¹¹. When the estrobolome is dysbiotic (often through antibiotic exposure, processed diet, or chronic inflammation), estrogen recirculates rather than leaving the body.

    There is one more layer specific to body composition. Aromatase, the enzyme in fat tissue that converts androgens to estrogen, is upregulated in conditions of inflammation, insulin resistance, and increased adiposity ¹². This creates the feedback loop that Elwin describes: more fat tissue produces more estrogen, more estrogen drives more fat storage in estrogen-sensitive areas, and the pattern reinforces itself.

    How This Pattern Develops

    Several specific drivers contribute to estrogen dominance.

    • Xenoestrogens. These are environmental compounds that mimic estrogen activity at the receptor level ¹³. The most studied include bisphenol A (BPA) found in plastics and thermal receipts, phthalates in personal care products, and certain pesticides. The cumulative load from modern environments is significant and was simply not present at this scale a generation ago ¹⁴.

    • Liver burden. Anything that taxes the liver, including alcohol, certain medications, processed food, and environmental toxins, can divert capacity away from estrogen clearance ¹⁵.

    • Gut dysbiosis. Modern diets, antibiotic exposure, and chronic stress disrupt the estrobolome, leading to enhanced beta-glucuronidase activity and estrogen recirculation ¹⁶.

    • Methylation impairment. Variations in the MTHFR gene, low folate or B12 intake, or alcohol consumption can reduce methylation capacity, slowing the most important Phase 2 pathway ¹⁷.

    • Adipose accumulation. As mentioned, fat tissue is hormonally active. The more adipose tissue, the more aromatase activity, the more endogenous estrogen production ¹⁸.

    • Chronic stress. Cortisol elevation diverts hormonal precursors away from progesterone production (sometimes described as the ‘pregnenolone steal’) ¹⁹, reducing the progesterone that would otherwise balance estrogen activity.

    • Perimenopause. The hormonal volatility of perimenopause can create relative estrogen dominance in many women, sometimes for years before menopause itself ²⁰.

    The Vicious Cycle

    The High Estrogen pattern is one of the more clearly self-reinforcing of the five Hormetics types. The mechanism is direct:

    • Adipose tissue produces estrogen via aromatase
    • Higher estrogen promotes fat storage in estrogen-sensitive areas
    • More fat tissue produces more aromatase activity
    • More aromatase activity produces more estrogen
    • Liver clearance becomes increasingly burdened
    • Gut dysbiosis allows further recirculation
    • The cycle deepens

    For both women and men, this pattern can persist for years and is often resistant to standard dietary approaches because the standard approaches do not address the clearance side of the equation.

    Why Conventional Approaches Often Fall Short

    Wellness apothecary still life on a marble counter: amber glass supplement bottles labeled 'Balance Complex,' 'Daily Detox,' and 'Hormonal Support,' a clear mug of herbal tea, and sprigs of rosemary and sage — symbolizing the search for hormonal balance

    Most of the popular discussion around estrogen tends to focus on either production or replacement: lower the estrogen, or supplement it during menopause. Both can be appropriate clinically. Neither, on its own, addresses the clearance pathway.

    For women, the standard approach to symptoms in the perimenopausal years is often hormonal contraception or hormone replacement therapy, which can be valuable but does not address the underlying detoxification capacity ²¹. For men, the popular discussion of testosterone has expanded considerably, but the relationship between testosterone and estrogen (mediated by aromatase activity in fat tissue) is less commonly addressed ²².

    For both sexes, standard dietary interventions often produce frustrating results in this pattern because the issue is not calorie balance but tissue-specific fat retention. Cellulite, lower body adiposity, and chest tissue changes are particularly resistant to standard caloric approaches because they are hormonally rather than calorically driven ²³.

    The deeper limitation is that conventional approaches tend to treat estrogen as a single number to be raised or lowered, rather than as a system involving production, balance, clearance, and recirculation.

    A Different Approach

    The High Estrogen framework starts from the recognition that the body's ability to process and eliminate estrogen is at least as important as its production.

    This is what the Hormetics system addresses for this type. The Estrogen Reset Protocol, co-developed by Elwin Robinson and Dr. Miriam Mikicki MD, works through the clearance pathways in a specific order. The details of the protocol are beyond the scope of this page, but the framework addresses liver detoxification capacity, gut estrobolome health, environmental xenoestrogen exposure, methylation support, and lifestyle factors that influence aromatase activity. The approach is the same regardless of sex, though the emphasis varies. Both women and men can present with this pattern, and the underlying mechanisms are largely the same.

    The first step is identifying which of the five Hormetics types applies to your specific situation.

    The Bigger Picture

    The High Estrogen pattern frequently overlaps with other Hormetics types. It commonly co-presents with leptin resistance because adipose tissue produces both leptin and estrogen ²⁴. It often appears alongside cortisol dominance because chronic stress reduces progesterone, leaving estrogen relatively unopposed ²⁵. Insulin resistance compounds the pattern by upregulating aromatase activity.

    If the description on this page sounds like your experience, the next step is the Hormetics Assessment.

    Already taken the assessment and know you're a Estrogen Type? If so, the following could help:

    The Estrogen Reset Protocol guide

    The Estrogen Reset Protocol

    What to eat, what to avoid, the supplements that support the pattern, and the daily rhythms that move the needle on healthy estrogen metabolism.

    Learn More
    Estrogen Balance Formula bottle

    Estrogen Balance Formula

    Formulated to support healthy estrogen metabolism and hormonal balance.†

    Learn More

    Important: The Hormetics framework is an educational system designed to support hormonal and metabolic optimization. It is not a substitute for medical evaluation, diagnosis, or treatment. If you have a medical condition, are taking medication, or have specific health concerns, consult with your healthcare provider before making changes. Individual results vary.

    Scientific Citations

    1. Lovejoy JC, et al. Sex differences in obesity and the role of sex hormones. Curr Opin Clin Nutr Metab Care. 1998. https://pmc.ncbi.nlm.nih.gov/articles/PMC12448628/
    2. Macut M, et al. Altered expression of aromatase and estrogen receptors in adipose tissue of men with obesity and insulin resistance. J Clin Endocrinol Metab. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12448628/
    3. Estrogen. StatPearls [Internet]. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC12448628/
    4. Santen RJ, et al. Metabolism and excretion of estrogens in humans. J Steroid Biochem Mol Biol. 2014;144 Pt B:122–135. https://pubmed.ncbi.nlm.nih.gov/14679015/
    5. Stanczyk FZ, et al. Progesterone and estrogen: roles in normal and abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2014. https://pmc.ncbi.nlm.nih.gov/articles/PMC12448628/
    6. Santen RJ, et al. Metabolism and excretion of estrogens in humans. https://pubmed.ncbi.nlm.nih.gov/14679015/
    7. Cavalieri E, Rogan E, et al. Catechol estrogen quinones as initiators of breast and other human cancers. Biochim Biophys Acta. 2004. https://pubmed.ncbi.nlm.nih.gov/14679015/
    8. Santen RJ, et al. (Phase 1 enzymes CYP1A1, 1B1, 3A4) https://pubmed.ncbi.nlm.nih.gov/14679015/
    9. Newman JW, et al. Methylation and estrogen metabolism. Mol Cell Endocrinol. 2009. https://pubmed.ncbi.nlm.nih.gov/14679015/
    10. Santen RJ, et al. (Phase 2 bottlenecks) https://pubmed.ncbi.nlm.nih.gov/14679015/
    11. Plottel CS, Blaser MJ. Microbiome and malignancy. Nat Rev Microbiol. 2011. https://pmc.ncbi.nlm.nih.gov/articles/PMC10416750/
    12. Xu Y, et al. The role of gut microbial β-glucuronidase in estrogen reactivation and breast cancer. Front Cell Dev Biol. 2021;9:631552. https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.631552/full
    13. Wang H, et al. Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism and health. Front Endocrinol (Lausanne). 2023;14:1180717. https://pmc.ncbi.nlm.nih.gov/articles/PMC10416750/
    14. Sprague BL, et al. Circulating serum xenoestrogens and mammographic breast density. Breast Cancer Res. 2013;15(3):R45. https://pmc.ncbi.nlm.nih.gov/articles/PMC4053153/
    15. Pop LJ, et al. Environmental chemicals and thyroid function. Endocr Rev. 2019. (xenoestrogens section) https://pmc.ncbi.nlm.nih.gov/articles/PMC5461198/
    16. Jimenez-Cruz R, et al. (liver burden / processed diet) https://pmc.ncbi.nlm.nih.gov/articles/PMC4248360/
    17. Wang H, et al. (gut dysbiosis / estrobolome) https://pmc.ncbi.nlm.nih.gov/articles/PMC10416750/
    18. Ziegler RG, et al. One-carbon metabolism, folate, and cancer risk. Cancer Causes Control. 2008. (methylation capacity) https://pubmed.ncbi.nlm.nih.gov/14679015/
    19. Subbaramaiah K, et al. Obesity is associated with inflammation-induced aromatase expression in the mouse mammary gland. J Biol Chem. 2011;286(45):39641–39647. https://pubmed.ncbi.nlm.nih.gov/22988244/
    20. Macut M, et al. (adipose aromatase) https://pmc.ncbi.nlm.nih.gov/articles/PMC12448628/
    21. Cadegiani FA, Kater CE. Adrenal fatigue does not exist: a systematic review. BMC Endocr Disord. 2016. (pregnenolone/cortisol stress map) https://pmc.ncbi.nlm.nih.gov/articles/PMC4997656/
    22. Santoro N. Perimenopause: from biology to clinical management. Endocrinol Metab Clin North Am. 2015;44(3):497–515. https://pmc.ncbi.nlm.nih.gov/articles/PMC12448628/
    23. The 2025 Menopausal Hormone Therapy Panel. The 2025 menopausal hormone therapy guidelines. J Menopausal Med. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12438153/
    24. Barot N, Bais A. Estrogen Therapy. StatPearls [Internet]. StatPearls Publishing; updated 2025. https://www.ncbi.nlm.nih.gov/books/NBK541051/
    25. Hugon-Rodin J, et al. Hormone Replacement Therapy. StatPearls [Internet]. StatPearls Publishing; updated 2024. https://www.ncbi.nlm.nih.gov/books/NBK493191/

    Medical Disclaimer: The information provided on this website and in our materials is for educational and informational purposes only and is not intended as medical advice. These statements have not been evaluated by the Food and Drug Administration. Our protocols and any referenced products are not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before starting any new diet, exercise, or supplement program.

    Results Disclaimer: Individual results may vary. Any testimonials or examples used on this page are not intended to represent or guarantee that anyone will achieve the same or similar results. Your specific outcomes depend on your individual baseline health, effort, and compliance with the protocol.

    Identify your Hormonal Archetype,
    Discover What's Been Working Against You
    Copyright © 2026 onwards. All rights reserved.

    Hormetics, Robinson Research Ltd, 128 City Road, London EC1V 2NX

    Support Email: support@hormetics.health

    We use cookies to ensure the best experience and for ad performance.